Allergan Eye Antibiotic Patent Claims Ruled Invalid
Lupin Ltd. and Hi-Tech Pharmacal Corp. infringed a patent relating to Allergan Inc.'s pinkeye treatments Zymaxid through their proposed generic versions of the antibiotics, but the asserted claims in the patent...To view the full article, register now.
Already a subscriber? Click here to view full article